Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart

Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart

US Patent 8796426 · Granted Aug 5, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vascular endothelial growth factor/anti-fibronectin antibody fusion proteins2022
Anti-αβTCR antibody2021
Methods for enhancing immunosuppressive therapy by multiple administration of αβ2021
IL2 and TNF mutant immunoconjugates2021
Specific and high affinity binding proteins comprising modified SH3 domains of F2021
Encoded self-assembling chemical libraries (ESACHEL)2021
IL22 immunoconjugates2020
Methods of treating a neoplastic disease2019
IL22 immunoconjugates2019
Production of encoded chemical libraries2019
Antigen associated with lung cancers and lymphomas2019
Small molecule drug conjugates2018